K191899: Glucose HK Gen.3, ISE indirect Na for Gen.2, Elecsys TSH, cobas pro integrated solutions (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K191899 (Glucose HK Gen.3, ISE indirect Na for Gen.2, Elecsys TSH, cobas pro integrated solutions, cleared 2019-08-16 for Roche Diagnostics) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K191899 |
| Cleared Device Trade / Generic Name | Glucose HK Gen.3, ISE indirect Na for Gen.2, Elecsys TSH, cobas pro integrated solutions |
| FDA Applicant on Filing | Roche Diagnostics |
| FDA 3-Letter Product Classification | Product Code CFR |
| FDA Substantial Equivalence Decision Date | 2019-08-16 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Roche / Genentech across sibling Meru public-data platforms.
Inspect consolidated manufacturer lineage at Roche Diagnostics, compare peer devices under FDA Product Code CFR, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.